A new treatment has been approved for extensive-stage small cell lung cancer
The MHRA has approved lurbinectedin (Zepzelca) as a new treatment option for adults with extensive-stage SCLC
24 Sep 10:52 · Open Access Government
last updated on 24 Sep 12:40